SynthesisFrontiers in medicine2026

Mass spectrometry-based proteomics and metabolomics in multiple myeloma: a systematic review of prognostic biomarkers and minimal residual disease monitoring.

Naseel Moursy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.